Skip to main content
Fig. 4 | Cardio-Oncology

Fig. 4

From: Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis

Fig. 4

Analysis of (a) left ventricular ejection fraction (LVEF) and (b) left ventricular global longitudinal strain (LVGLS) with anthracycline exposure. (c) Correlation of change in LVEF with interval change in 5th generation high-sensitivity cardiac troponin T (cTnT) from Pre-chemo to End-Chemo. (d) Correlation of change in LVEF with interval change in galectin-3 (Gal3) from Pre-Chemo to End-Chemo. ** p < 0.0001, * p < 0.05

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us